Is It Ethical to Test Apparently "Healthy" Children for Autosomal Dominant Polycystic Kidney Disease and Risk Medicalizing Thousands?

about

Is It Ethical to Test Apparently "Healthy" Children for Autosomal Dominant Polycystic Kidney Disease and Risk Medicalizing Thousands?

Item

http://www.wikidata.org/entity/Q49305361

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@en

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@nl

type

Item

label

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@en

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@nl

prefLabel

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@en

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@nl

P1476

Is It Ethical to Test Apparent ...... d Risk Medicalizing Thousands?

@en

P2093

Tess Harris

http://www.w3.org/2001/XMLSchema#string

P2860

ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival--an analysis of data from the ERA-EDTA Registry.

Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics.

Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Type of PKD1 mutation influences renal outcome in ADPKD.

Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history

Medicalisation and Overdiagnosis: What Society Does to Medicine.

Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.

P304

291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPED.2017.00291

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29404310

http://www.w3.org/2001/XMLSchema#string

P921

autosomal dominant polycystic kidney disease

medical ethics

P932

5780433

http://www.w3.org/2001/XMLSchema#string